First Quadrant’s GSK GSK Stock Holding History

First Quadrant’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-4,560	Closed	-$286K	–	802
2013 Q3	$286K	Sell	4,560 -3,040	-40%	-$196K	0.01%	506
2013 Q2	$475K	Buy	+7,600	New	+$482K	0.01%	447

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Quadrant's GSK Position: Q4 2013 in Review

First Quadrant sold out of GSK (GSK) in Q4 2013, closing a stake of 4,560 shares — an estimated $286K sold.

First Quadrant first reported a position in GSK in Q2 2013 and held it in 2 quarters. The position peaked at $475K in Q2 2013. 681 funds tracked by Wall St. Rank hold GSK as of Q4 2013.

First Quadrant reported no remaining GSK position as of Q4 2013 after selling out during the quarter.
First Quadrant sold 4,560 GSK shares in Q4 2013, an estimated $286K.
First Quadrant first reported a position in GSK in Q2 2013 and held it in 2 quarters.
First Quadrant's GSK position peaked at $475K in Q2 2013.
681 funds tracked by Wall St. Rank held GSK as of Q4 2013.

Based on First Quadrant's 13F filing for Q4 2013, filed 29 Jan 2014.